Genetic Testing Market to reach a market size of $16.9 billion by 2025

According to a new report ****** Genetic Testing Market, published by KBV Research, The ****** Genetic Testing Market size is expected to reach $16.9 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period.

The North America market dominated the ****** Predictive and Presymptomatic Testing Market by Region in 2018, growing at a CAGR of 11.8 % during the forecast period. The Europe market is expected to witness a CAGR of 12% during (2019­-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 13.9% during (2019-2025).

The Molecular Testing market dominated the ****** Genetic Testing Market by Technology in 2018, growing at a CAGR of 11 % during the forecast period. The Biochemical Testing market is expected to witness a CAGR of 11.7% during (2019-2025).

The Genetic Disease Diagnosis market dominated the ****** Genetic Testing Market by Application in 2018, growing at a CAGR of 10.7 % during the forecast period. The Cancer Diagnosis market is expected to witness a CAGR of 10.7% during (2019-2025).

Full Report: https://www.kbvresearch.com/genetic-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).

****** Genetic Testing Market Segmentation

By Type

Predictive and Presymptomatic Carrier Testing

Prenatal and Newborn Testing

Diagnostic Testing

Pharmacogenomic Testing

Other Types

By Technology

Cytogenetic Testing

Biochemical Testing and

Molecular Testing

By Application

Cancer Diagnosis

Genetic Disease Diagnosis

Cardiovascular Disease Diagnosis and

Other Applications

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

Myriad Genetics, Inc.

Empire Genomics LLC

Bio-Rad Laboratories, Inc.

Novartis AG

Agilent Technologies, Inc.

Thermo Fisher Scientific, Inc.

Qiagen N.V.

Illumina, Inc.

Danaher Corporation

Abbott Laboratories (Abbott Laboratories Molecular, Inc.)

Genetic Testing Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.